Ciprofol-Esketamine Versus Ciprofol-Remifentanil in Hysteroscopic Endometrial Polypectomy: A Randomized Controlled Trial
Medical Science Monitor · 02.06.2026 · 32
DOI: 10.12659/msm.952468 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Medical Science Monitor, online erschienen am 02.06.2026. Verfasst von Zhong Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Affiliated Huishan Hospital of Xinglin College, Nantong University, Wuxi Huishan District People's Hospital, Wuxi, Jian…. Hauptthemen laut MEDLINE: Remifentanil, Hysteroscopy, Polyps, Ketamine. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Affiliated Huishan Hospital of Xinglin College, Nantong University, Wuxi Huishan District People's Hospital, Wuxi, Jiangsu, China.
Zitieren
APA
Zhang, Z., Wang, Z., Gong, W., Jiang, W., Zheng, L., & Yu, Z. (2026). Ciprofol-Esketamine Versus Ciprofol-Remifentanil in Hysteroscopic Endometrial Polypectomy: A Randomized Controlled Trial. Medical Science Monitor, 32. https://doi.org/10.12659/msm.952468
Vancouver
Zhang Z, Wang Z, Gong W, Jiang W, Zheng L, Yu Z. Ciprofol-Esketamine Versus Ciprofol-Remifentanil in Hysteroscopic Endometrial Polypectomy: A Randomized Controlled Trial. Medical Science Monitor. 2026;32. doi:10.12659/msm.952468
BibTeX
@article{Zhang2026,
author = {Zhang, Zhong and Wang, Zhixu and Gong, Wanwan and Jiang, Wei and Zheng, Longjiao and Yu, Zhiyang},
title = {Ciprofol-Esketamine Versus Ciprofol-Remifentanil in Hysteroscopic Endometrial Polypectomy: A Randomized Controlled Trial},
journal = {Medical Science Monitor},
year = {2026},
volume = {32},
doi = {10.12659/msm.952468}
}
EUVIMED